Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA randomised controlled trial

Larisa Duffy; Gemma Lewis; Anthony Ades; Ricardo Araya; Jessica Bone; Sally Brabyn; Katherine Button; Rachel Churchill; Tim Croudace; Catherine Derrick; Padraig Dixon; Christopher Dowrick; Christopher Fawsitt; Louise Fusco; Simon Gilbody; Catherine Harmer; Catherine Hobbs; William Hollingworth; Vivien Jones; Tony Kendrick; David Kessler; Naila Khan; Daphne Kounali; Paul Lanham; Alice Malpass; Marcus Munafo; Jodi Pervin; Tim Peters; Derek Riozzie; Jude Robinson; George Salaminios; Debbie Sharp; Howard Thom; Laura Thomas; Nicky Welton; Nicola Wiles; Rebecca Woodhouse; Glyn Lewis

Appendix 12Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA randomised controlled trial

See Hollingworth et al.⁴⁵

Publication Details

Copyright

Copyright © Queen’s Printer and Controller of HMSO 2019. This work was produced by Duffy et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Publisher

NIHR Journals Library, Southampton (UK)

NLM Citation

Duffy L, Lewis G, Ades A, et al. Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT. Southampton (UK): NIHR Journals Library; 2019 Dec. (Programme Grants for Applied Research, No. 7.10.) Appendix 12, Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA randomised controlled trial.